Literature DB >> 1332979

Overexpression of human alpha-galactosidase A results in its intracellular aggregation, crystallization in lysosomes, and selective secretion.

Y A Ioannou1, D F Bishop, R J Desnick.   

Abstract

Human lysosomal alpha-galactosidase A (alpha-Gal A) was stably overexpressed in CHO cells and its biosynthesis and targeting were investigated. Clone AGA5.3-1000Mx, which was the highest enzyme overexpressor, produced intracellular alpha-Gal A levels of 20,900 U/mg (approximately 100 micrograms of enzyme/10(7) cells) and secreted approximately 13,000 U (or 75 micrograms/10(7) cells) per day. Ultrastructural examination of these cells revealed numerous 0.25-1.5 microns crystalline structures in dilated trans-Golgi network (TGN) and in lysosomes which stained with immunogold particles using affinity-purified anti-human alpha-Gal A antibodies. Pulse-chase studies revealed that approximately 65% of the total enzyme synthesized was secreted, while endogenous CHO lysosomal enzymes were not, indicating that the alpha-Gal A secretion was specific. The recombinant intracellular and secreted enzyme forms were normally processed and phosphorylated; the secreted enzyme had mannose-6-phosphate moieties and bound the immobilized 215-kD mannose-6-phosphate receptor (M6PR). Thus, the overexpressed enzyme's selective secretion did not result from oversaturation of the M6PR-mediated pathway or abnormal binding to the M6PR. Of note, the secreted alpha-Gal A was sulfated and the percent of enzyme sulfation decreased with increasing amplification, presumably due to the inaccessibility of the enzyme's tyrosine residues for the sulfotransferase in the TGN. Overexpression of human lysosomal alpha-N-acetylgalactosaminidase and acid sphingomyelinase in CHO cell lines also resulted in their respective selective secretion. In vitro studies revealed that purified secreted alpha-Gal A was precipitated as a function of enzyme concentration and pH, with 30% of the soluble enzyme being precipitated when 10 mg/ml of enzyme was incubated at pH 5.0. Thus, it is hypothesized that these overexpressed lysosomal enzymes are normally modified until they reach the TGN where the more acidic environment of this compartment causes the formation of soluble and particulate enzyme aggregates. A significant proportion of these enzyme aggregates are unable to bind the M6PR and are selectively secreted via the constitutive secretory pathway, while endogenous lysosomal enzymes bind the M6PRs and are transported to lysosomes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332979      PMCID: PMC2289730          DOI: 10.1083/jcb.119.5.1137

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  48 in total

1.  Reconstitution of steps in the constitutive secretory pathway in permeabilized cells. Secretion of glycosylated tripeptide and truncated sphingomyelin.

Authors:  J B Helms; A Karrenbauer; K W Wirtz; J E Rothman; F T Wieland
Journal:  J Biol Chem       Date:  1990-11-15       Impact factor: 5.157

2.  High level expression of functional full length and truncated glucocorticoid receptor in Chinese hamster ovary cells. Demonstration of ligand-induced down-regulation of expressed receptor mRNA and protein.

Authors:  M Alksnis; T Barkhem; P E Strömstedt; H Ahola; E Kutoh; J A Gustafsson; L Poellinger; S Nilsson
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

3.  Expression and maturation of human cathepsin D in baby-hamster kidney cells.

Authors:  M Horst; A Hasilik
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

4.  Selection and coamplification of heterologous genes in mammalian cells.

Authors:  R J Kaufman
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

5.  A practical chromogenic procedure for the detection of homozygotes and heterozygous carriers of Niemann-Pick disease.

Authors:  A E Gal; R O Brady; S R Hibbert; P G Pentchev
Journal:  N Engl J Med       Date:  1975-09-25       Impact factor: 91.245

6.  The stress response in Chinese hamster ovary cells. Regulation of ERp72 and protein disulfide isomerase expression and secretion.

Authors:  A J Dorner; L C Wasley; P Raney; S Haugejorden; M Green; R J Kaufman
Journal:  J Biol Chem       Date:  1990-12-15       Impact factor: 5.157

7.  Identification of point mutations in the alpha-galactosidase A gene in classical and atypical hemizygotes with Fabry disease.

Authors:  H Sakuraba; A Oshima; Y Fukuhara; M Shimmoto; Y Nagao; D F Bishop; R J Desnick; Y Suzuki
Journal:  Am J Hum Genet       Date:  1990-11       Impact factor: 11.025

8.  High mutation frequency in DNA transfected into mammalian cells.

Authors:  M P Calos; J S Lebkowski; M R Botchan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Invariant exon skipping in the human alpha-galactosidase A pre-mRNA: Ag+1 to t substitution in a 5'-splice site causing Fabry disease.

Authors:  H Sakuraba; C M Eng; R J Desnick; D F Bishop
Journal:  Genomics       Date:  1992-04       Impact factor: 5.736

View more
  35 in total

1.  Hepatic and intestinal transplantation at the University of Pittsburgh.

Authors:  K Abu-Elmagd; J Fung; J Reyes; A Rao; A Jain; G Mazariegos; W Marsh; J Madariaga; I Dvorchik; J Bueno; J Rogers; J McMichael; F Dodson; H Vargus; J Martin; A Slivka; V Balan; R Corry; J Rakela; N Murase; J Demetris; S Iwatsuki; T Starzl
Journal:  Clin Transpl       Date:  1998

2.  A revisited folding reporter for quantitative assay of protein misfolding and aggregation in mammalian cells.

Authors:  Simpson Gregoire; Inchan Kwon
Journal:  Biotechnol J       Date:  2012-06-27       Impact factor: 4.677

3.  Human alpha-galactosidase A: high plasma activity expressed by the -30G-->A allele.

Authors:  T F Fitzmaurice; R J Desnick; D F Bishop
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

4.  Effect of single-nucleotide polymorphisms of the 5' untranslated region of the human α-galactosidase gene on enzyme activity, and their frequencies in Portuguese caucasians.

Authors:  J P Oliveira; S Ferreira; J Barceló; P Gaspar; F Carvalho; M C Sá Miranda; J-E Månsson
Journal:  J Inherit Metab Dis       Date:  2008-11-03       Impact factor: 4.982

Review 5.  Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives.

Authors:  Melani Solomon; Silvia Muro
Journal:  Adv Drug Deliv Rev       Date:  2017-05-11       Impact factor: 15.470

6.  Cis-suppression to arrest protein aggregation in mammalian cells.

Authors:  Simpson Gregoire; Shaojie Zhang; Joseph Costanzo; Kelly Wilson; Erik J Fernandez; Inchan Kwon
Journal:  Biotechnol Bioeng       Date:  2013-10-18       Impact factor: 4.530

7.  Recombinant enzyme therapy for Fabry disease: absence of editing of human alpha-galactosidase A mRNA.

Authors:  Daniël Blom; Dave Speijer; Gabor E Linthorst; Wilma G Donker-Koopman; Anneke Strijland; Johannes M F G Aerts
Journal:  Am J Hum Genet       Date:  2002-12-06       Impact factor: 11.025

8.  Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis.

Authors:  L Lin; P Lobel
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

9.  Human alpha-galactosidase A: glycosylation site 3 is essential for enzyme solubility.

Authors:  Y A Ioannou; K M Zeidner; M E Grace; R J Desnick
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

Review 10.  Enzyme replacement and enhancement therapies for lysosomal diseases.

Authors:  R J Desnick
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.